Fondo Bibliografico Internacional Julio 2003
Hepatitis
Quality of life and cognitive function in hepatitis
C at different stages of liver disease. Cordoba J, Flavia M, Jacas C, Sauleda
S, Esteban JI, Vargas V, Esteban R, Guardia J. Journal of Hepatology 2003;39:231-8.
Menor calidad de vida relacionada con la intensidad
de la hepatitis crónica C.
Prediction of liver histological lesions with biochemical
markers in patients with chronic hepatitis B. Myers RP, Tainturier MH, Ratziu
V, Piton A, Thibault V, Imbert-Bismut F, Messous D, Charlotte F, Di Martino
V, Benhamou Y, Poynard T. Journal of Hepatology 2003;39:222-30.
Las transaminasas y el Fibrotest son buenos indicadores
de la intensidad de la fibrosis en la hepatitis crónica por VHB.
Interferon-alpha 2b Induction Treatment with or Without Ribavirin
in Chronic Hepatitis C: A Multicenter, Randomized, Controlled Trial. Hakan
Senturk, Galip Ersoz, Resat Ozaras, et al. Digestive Diseases and Science
2003;48:1124-1129.
Interferón-alfa 2b + ribavirina es superior
al tratamiento con interferón-alfa 2b en pacientes con hepatitis crónica
VHC y genotipo 1.
Regression of Fibrosis in Chronic Hepatitis C After Therapy
with Interferon and Ribavirin. Asma Arif, Robert A. Levine, Schuyler O. Sanderson,
et al. Digestive Diseases and Science 2003;48:1425-1430.
Regresión de la fibrosis en pacientes con
hepatitis crónica VHC en tratamiento con interferón y ribavirina.
Hyperlipasemia Associated with Hepatitis C Virus. Boris Yoffe,
Anita S. Bagri, Thomas Tran, et al. Digestive Diseases and Science 2003;48:1648-1653.
Hiperlipasemia como posible manifestación
extrahepática de la infección por el virus de la hepatitis C.
Interferon-a for Reinfection with Hepatitis C Virus in Two
Patients with Chronic Hepatitis C Who Had Responded to Previous Therapies.
Norio Akuta, Fumitaka Suzuki, Akihito Tsubota, et al. Digestive Diseases and
Science 2003;48:1654-1657.
Caso clínico.
Anticardiolipin antibodies in chronic viral hepatitis. Do
they have clinical consequences? José R. Yuste; Jesús Prieto.
European Journal of Gastroenterology and Hepatology 2003;15:717-720.
Editorial.
Anticardiolipin antibodies in chronic hepatitis B and chronic
hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship
with portal vein thrombosis. Ioannis S. Elefsiniotis; Ioannis D. Diamantis;
Spyros P. Dourakis, et al. European Journal of Gastroenterology and Hepatology
2003;15:721-726.
Prevalencia de anticuerpos anticardiolipina en pacientes
con hepatitis crónica VHB.
Outbreak of hepatitis A in the injecting drug user and homeless
populations in Bristol: control by a targeted vaccination programme and possible
parenteral transmission. Naveed A. Syed; Stephen D. Hearing; Ian S. Shaw,
et al. European Journal of Gastroenterology and Hepatology 2003;15:901-906.
Eficacia de una estrategia de vacunación en
el control de un brote de hepatitis A en adictos a drogas por vía parenteral.
Relevance of hepatitis B core gene deletions in patients after
kidney transplantation. C.-Thomas Bock, Boris Buerke, Hans L. Tillmann, et
al. Gastroenterology 2003;124 :1809-1820.
Deleciones en el gen core de la hepatitis B se asocian
a un curso agresivo de la enfermedad hepática en pacientes receptores
de trasplante renal.
Spontaneous resolution of chronic hepatitis C virus disease
after withdrawal of immunosuppression. Ma Somsouk, Georg M. Lauer, Deborah
Casson, et al. Gastroenterology 2003;124 :1946-1949.
Caso clínico.
Acute hepatitis C: High rate of both spontaneous and treatment-induced
viral clearance. J. Tilman Gerlach, Helmut M. Diepolder, Reinhart Zachoval,
et al. Gastroenterology 2003;125:80-88.
Hepatitis aguda C sintomática: alta tasa de
aclaramiento viral espontáneo durante los tres meses posteriores al
evento clínico.
New insights into acute hepatitis C. Stuart C. Gordon.
Gastroenterology 2003;125:253-255.
Editorial
